Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This single-arm, open-label, multi-center study enrolled 65 patients from approximately 20
centers. All patients who met the study criteria and were taking, beginning or resuming
treatment with Deferasirox were allowed. The study will began with a one month run-in phase,
where all patients were instructed to take Deferasirox according to their physician's
prescribing information.